GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Golden Biotechnology Corp (ROCO:4132) » Definitions » YoY EBITDA Growth

Golden Biotechnology (ROCO:4132) YoY EBITDA Growth : -17.89% (As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Golden Biotechnology YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Golden Biotechnology's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was -17.89%.

Golden Biotechnology's EBITDA per Share for the six months ended in Jun. 2024 was NT$-0.88.


Golden Biotechnology YoY EBITDA Growth Historical Data

The historical data trend for Golden Biotechnology's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Golden Biotechnology YoY EBITDA Growth Chart

Golden Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.68 -42.77 -12.12 47.94 -40.21

Golden Biotechnology Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.43 81.65 37.27 -432.20 -17.89

Golden Biotechnology YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Golden Biotechnology's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-2.005--1.43)/ | -1.43 |
=-40.21 %

Golden Biotechnology's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (Q: Jun. 2024 )
=(EBITDA per Share (Q: Jun. 2024 )-EBITDA per Share (Q: Jun. 2023 )) / | EBITDA per Share (Q: Jun. 2023 )) |
=(-0.883--0.749)/ | -0.749 |
=-17.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Golden Biotechnology YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Golden Biotechnology's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Golden Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
15F, No. 27-6, Sec. 2, Chung Cheng East Road, Danshuie Township, Taipei, TWN, 251
Golden Biotechnology Corp is a Taiwan based company engages in the production of drugs and herbal supplement. It specializes in anti-cancer and anti-atherosclerosis drugs.

Golden Biotechnology Headlines

No Headlines